My 10-share stock market portfolio for future growth

I have invested in a stock market portfolio of FTSE 350 shares that I expect to continue outperforming these indices over the medium to long term.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Inflation is rampant worldwide. Nevertheless, I believe that — in these difficult times — stock markets still offer the best investment hedge against inflation and excellent long-term return potential for carefully selected shares.

My portfolio

FTSEShareCodeMarket cap (£bn)IndustryYTD % performanceOne-year % performanceThree-year % performance
100AstraZenecaAZN175.8Pharmaceuticals24.1526.5147.23
250BeazleyBEZ3.5Insurance22.1345.240.00
100BunzlBNZL10.6Distribution, logistics-0.358.3342.82
250CapricornCNE0.7Oil, Gas Exploration25.9722.3942.21
100GlencoreGLEN64.9Mining & Trading30.3649.76108.12
250HuntingHTG0.5Energy Industry supplier68.4439.02-37.64
250IndiviorINDV2.1Pharmaceuticals12.0645.31377.45
250MediclinicMDC3.7Health55.5658.1246.85
250SercoSRP2.1Government Services32.1733.5621.93
100SSESSE19.4Power Generation2.512.3046.87
PortfolioAs at 31.8.2227.3033.0569.58

On an equal invested value basis, the portfolio has grown by 69.6% over the past three years (+19.2% per annum). While past performance is no guarantee of future performance, medium to long term I expect the overall portfolio to outperform the FTSE 100 and FTSE 250 indices.

One or two of the stocks may disappoint. Hence, I will actively manage the portfolio and substitute any stocks for which the prospects deteriorate.

AstraZeneca

A British-Swedish multinational pharmaceutical and biotechnology company. It was at the forefront of the rush to develop and distribute a vaccine for Covid-19. Its innovative medicines are used by millions of patients worldwide.

Beazley

A British parent company of worldwide insurance businesses. It underwrites a diverse book of insurance and reinsurance for clients and is a market leader in many of its chosen lines.

Bunzl

A British multinational distribution and outsourcing company. Over 50% of its business is in the food service and food retail sectors.

Capricorn Energy  (previously Cairn Energy)

A British oil and gas exploration and development company. Despite Britain’s net zero objectives, as green billionaire Elon Musk says, “civilization would crumble” if the world stops drilling for oil and gas.

Glencore

An Anglo-Swiss company. One of the world’s largest globally diversified natural resource businesses, being both a mining company and the world’s largest commodities trading firm.

Hunting

A British-based supplier to the oil and gas industry.

Indivior  

A global pharmaceutical company specialising in developing medicines to treat substance use disorders and serious mental illnesses.

Mediclinic International

An international private hospital group with hospitals in South Africa, Namibia, Switzerland and the United Arab Emirates.

Serco

A British contractor for the supply of Government services, primarily in the health, transport, justice, immigration, space, and defense sectors. 55% of the company’s revenue is generated outside the UK.

SSE

Formerly Southern and Scottish Energy, SSE is a multinational energy company that operates UK power stations and offshore wind farms and has a hydroelectric plant in Scotland.

Ian Benfield has positions in AstraZeneca, Beazley, Bunzl, Capricorn Energy, Glencore, Hunting, Indivior, Mediclinic, Serco and SSE. The Motley Fool UK has recommended Bunzl. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

ISA coins
Dividend Shares

4 UK shares that could provide a 10%+ annual ISA return

Jon Smith points out several stocks that could be included in a diversified ISA portfolio to help generate a yield…

Read more »

British pound data
Investing Articles

3 shares to consider buying as the FTSE 100 plummets

For those with cash on the sidelines and a long-term horizon, an equity market slump is less of a crisis…

Read more »

Calendar showing the date of 5th April on desk in a house
Investing Articles

2 FTSE 100 blue-chips to consider for a Stocks and Shares ISA before 5 April

Looking for ideas for a Stocks and Shares ISA before the forthcoming allowance deadline? Ben McPoland highlights two FTSE 100…

Read more »

Storytelling image of a multiethnic senior couple in love - Elderly married couple dating outdoors, love emotions and feelings
Investing Articles

How much will you need in a SIPP to earn a £3k monthly passive income in 2053?

A SIPP can be an exceptional wealth-building tool. Royston Wild explains how -- and reveals a top FTSE 100 dividend…

Read more »

Happy retired couple on a yacht
Investing Articles

3 easy steps to target a £1,000,000 Stocks and Shares ISA!

Looking to get a seat on millionaire's row? Royston Wild reveals three top strategies that could supercharge your Stocks and…

Read more »

Calendar showing the date of 5th April on desk in a house
Investing Articles

3 things to do right now as the annual ISA deadline looms!

With the ISA contribution deadline less than three weeks away, our writer runs through a trio of things he has…

Read more »

piggy bank, searching with binoculars
Growth Shares

It could be a once-in-a-decade opportunity to buy this cheap FTSE 250 stock

Jon Smith points out a FTSE 250 stock he's weighing up as to whether it could be a rare opportunity…

Read more »

Close-up image depicting a woman in her 70s taking British bank notes from her colourful leather wallet.
Investing Articles

At over 10%, I couldn’t resist this FTSE 250 share’s yield!

Christopher Ruane explains why he has bought into a 10%+ yielding FTSE 250 income share that the market has lately…

Read more »